Micronuclei in human peripheral blood and bone marrow as genotoxicity markers: A systematic review and meta-analysis

Mutat Res Genet Toxicol Environ Mutagen. 2023 Oct:891:503689. doi: 10.1016/j.mrgentox.2023.503689. Epub 2023 Sep 4.

Abstract

Can human peripheral blood cells be used as a surrogate for bone marrow cells, in evaluating the genotoxic effects of stressors? We searched the Pubmed/Medline and PubChem databases to identify publications relevant to this question. Micronucleus formation was the genotoxicity endpoint. Three publications comparing exposed vs. non-exposed individuals are included in this analysis; the exposures were to ethylene oxide or ionising radiation (atomic bomb, thorotrast, or radioiodine therapy). Information was extracted on the types of exposure, the numbers of participants, and the micronucleus frequencies. Relative differences (odds ratios) and absolute differences (risk differences) in the numbers of micronuclei between exposed and non-exposed persons were calculated separately for individual cell types (peripheral blood and bone marrow). Random effects meta-analyses for the relative differences in cell abnormalities were performed. The results showed very small differences in the frequencies of micronuclei between exposed and non-exposed individuals, as measured in either peripheral blood or bone marrow cell populations, on both absolute and relative scales. No definite conclusion concerning the relative sensitivities of bone marrow and peripheral blood cells can be made, based on these publications.

Keywords: Bone marrow; Genotoxicity; Meta-analysis; Micronuclei; Peripheral blood; Systematic review.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Blood Cells
  • Bone Marrow Cells
  • Bone Marrow*
  • DNA Damage
  • Humans
  • Iodine Radioisotopes* / pharmacology
  • Micronuclei, Chromosome-Defective
  • Micronucleus Tests / methods

Substances

  • Iodine Radioisotopes